THE ISRAEL INSTITUTE OF BIOLOGICAL RES IIBR has a total of 11 patent applications. It increased the IP activity by 33.0%. Its first patent ever was published in 2015. It filed its patents most often in Israel, United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are KOMED CO LTD, RES ASS FOR BIOTECHNOLOGY and CLONATEC SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 5 | |
#2 | United States | 5 | |
#3 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Analysing materials | |
#5 | Measuring microorganism processes | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Mazor Ohad | 4 |
#2 | Noy-Porat Tal | 3 |
#3 | Rosenfeld Ronit | 2 |
#4 | Beth-Din Adi | 2 |
#5 | Israeli Ofir | 2 |
#6 | Ordentlich Arie | 2 |
#7 | Sabo Tamar | 2 |
#8 | Cohen Ofer | 2 |
#9 | Falach Reut | 2 |
#10 | Shifman Ohad | 2 |
Publication | Filing date | Title |
---|---|---|
IL260412D0 | Anti francisella tularensis (ft) antibodies | |
IL252188D0 | Detection of exposure to rip ii toxins | |
US2017174752A1 | Antibodies directed to ricin toxin | |
IL249926D0 | Antibodies directed to ricin toxin | |
US2016289657A1 | Acetylcholinesterase-Fc domain fusion protein | |
US2016152732A1 | Antibodies directed to ricin toxin |